Rick Player

517 total citations
8 papers, 400 citations indexed

About

Rick Player is a scholar working on Infectious Diseases, Epidemiology and Pharmacology. According to data from OpenAlex, Rick Player has authored 8 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Epidemiology and 2 papers in Pharmacology. Recurrent topics in Rick Player's work include Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). Rick Player is often cited by papers focused on Pneumonia and Respiratory Infections (3 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers) and Hemoglobinopathies and Related Disorders (2 papers). Rick Player collaborates with scholars based in United States, Canada and Germany. Rick Player's co-authors include R. Rex Williams, Adalberto Sperb Rubin, John Segreti, L. A. Dunbar, Richard Köhler, Thomas M. File, Josef T. Prchal, Alan Wells, Peter D. Emanuel and Richard N. Greenberg and has published in prestigious journals such as New England Journal of Medicine, Antimicrobial Agents and Chemotherapy and Clinical Therapeutics.

In The Last Decade

Rick Player

8 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rick Player United States 6 273 164 108 53 51 8 400
V Drossou-Agakidou Greece 10 126 0.5× 109 0.7× 98 0.9× 77 1.5× 49 1.0× 14 380
Helen M. Crowe United States 9 126 0.5× 62 0.4× 34 0.3× 68 1.3× 34 0.7× 16 262
Loretta Wubbel United States 9 403 1.5× 139 0.8× 64 0.6× 37 0.7× 68 1.3× 16 515
Maia De Luca Italy 10 201 0.7× 44 0.3× 34 0.3× 75 1.4× 36 0.7× 39 361
Emanuela Biagioni Italy 10 103 0.4× 31 0.2× 39 0.4× 44 0.8× 21 0.4× 31 265
Benjamin Clouzeau France 11 85 0.3× 54 0.3× 21 0.2× 47 0.9× 94 1.8× 20 412
Kirsten van de Groep Netherlands 9 144 0.5× 12 0.1× 23 0.2× 41 0.8× 19 0.4× 13 267
R Hullmann Germany 5 159 0.6× 243 1.5× 79 0.7× 62 1.2× 33 0.6× 10 407
José Tiago Silva Spain 11 215 0.8× 50 0.3× 62 0.6× 190 3.6× 58 1.1× 29 358
Sanjay Biswas India 11 106 0.4× 44 0.3× 88 0.8× 61 1.2× 40 0.8× 41 330

Countries citing papers authored by Rick Player

Since Specialization
Citations

This map shows the geographic impact of Rick Player's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rick Player with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rick Player more than expected).

Fields of papers citing papers by Rick Player

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rick Player. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rick Player. The network helps show where Rick Player may publish in the future.

Co-authorship network of co-authors of Rick Player

This figure shows the co-authorship network connecting the top 25 collaborators of Rick Player. A scholar is included among the top collaborators of Rick Player based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rick Player. Rick Player is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Criner, Gerard J., et al.. (2008). Efficacy of Tiotropium Inhalation Powder in African-American Patients with Chronic Obstructive Pulmonary Disease. COPD Journal of Chronic Obstructive Pulmonary Disease. 5(1). 35–41. 21 indexed citations
2.
Fogarty, Charles, Richard N. Greenberg, Lala M. Dunbar, et al.. (2001). Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials. Clinical Therapeutics. 23(3). 425–439. 27 indexed citations
3.
Segreti, John, L. A. Dunbar, Rick Player, et al.. (1998). A Multicenter, Randomized Study Comparing the Efficacy and Safety of Intravenous and/or Oral Levofloxacin versus Ceftriaxone and/or Cefuroxime Axetil in Treatment of Adults with Community-Acquired Pneumonia. Infectious Diseases in Clinical Practice. 7(2). 88–88. 11 indexed citations
4.
File, Thomas M., John Segreti, L. A. Dunbar, et al.. (1997). A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrobial Agents and Chemotherapy. 41(9). 1965–1972. 281 indexed citations
5.
Wells, Alan, et al.. (1996). Sickle cell acute chest syndrome associated with parvovirus B19 infection: Case series and review. American Journal of Hematology. 51(3). 207–213. 43 indexed citations
6.
Wells, Alan, et al.. (1996). Sickle cell acute chest syndrome associated with parvovirus B19 infection: Case series and review. American Journal of Hematology. 51(3). 207–213. 3 indexed citations
7.
Player, Rick, James Richards, Connie L. Kohler, et al.. (1994). Scale for Assessing Functional Impairment in Adults with Asthma. Journal of Asthma. 31(6). 437–444. 13 indexed citations
8.
Michael, Max & Rick Player. (1991). Book Review Conn's Current Therapy 1991 Edited by Robert E. Rakel. 1192 pp. Philadelphia, W.B. Saunders, 1991. $49.95.. New England Journal of Medicine. 325(4). 288–288. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V Drossou-Agakidou Breakdown of academic impact, for papers by Helen M. Crowe Breakdown of academic impact, for papers by Loretta Wubbel Breakdown of academic impact, for papers by Maia De Luca Breakdown of academic impact, for papers by Emanuela Biagioni Breakdown of academic impact, for papers by Benjamin Clouzeau Breakdown of academic impact, for papers by Kirsten van de Groep Breakdown of academic impact, for papers by R Hullmann Breakdown of academic impact, for papers by José Tiago Silva Breakdown of academic impact, for papers by Sanjay Biswas
Rankless by CCL
2026